Business Wire
Clovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
Tuesday, 01 January 2019 23:06
Clovis OncologyAnna Sussman303.625.5022 This e-mail address is being protected from spambots. You need JavaScript enabled to view it orBreanna Burkart303.625.5023 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Clovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
Tuesday, 01 January 2019 23:06
Clovis OncologyAnna Sussman303.625.5022 This e-mail address is being protected from spambots. You need JavaScript enabled to view it orBreanna Burkart303.625.5023 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7
Tuesday, 01 January 2019 22:06
Webcast Available Through Gilead Corporate Website
Read more...
 
First-in-human Study of Precision Immune Stimulant PIN-2 Demonstrated Pharmacologic Activity and Safety in Patients with Advanced Solid Tumors
Tuesday, 01 January 2019 22:06
Read more...
 
Propanc Biopharma Commences Drug Discovery Research Collaboration
Tuesday, 01 January 2019 22:06
University of Jaén to Co-fund 3 to 4 Year Program, Appoints Scientist to Lead Research Activities
Read more...
 
Axonics® Submits Interim Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System
Tuesday, 01 January 2019 22:06
Axonics’ ContactAxonics Modulation Technologies, Inc.Dan Dearen, +1-949-396-6320President & Chief Financial Officer This e-mail address is being protected from spambots. You need JavaScript enabled to view it Investor & Media ContactW2OpureMatt Clawson, +1-949-370-8500 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Atreca to Present at the 37th Annual J.P. Morgan Healthcare Conference
Tuesday, 01 January 2019 22:06
Robert Flamm, 212-213-0006, ext. 364
Read more...
 
Ironwood and Allergan Announce Settlement with Mylan Resolving LINZESS® (linaclotide) Patent Litigation
Tuesday, 01 January 2019 22:06
Meredith KayaIronwood Investor and Media Relations617-374-5082 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Vertex to Present at the J.P. Morgan Healthcare Conference on January 7
Tuesday, 01 January 2019 22:06
Vertex Pharmaceuticals IncorporatedInvestors:Michael Partridge, 617-341-6108Eric Rojas, 617-961-7205Zach Barber, 617-341-6470
Read more...
 
UAE In-Vitro Diagnostics Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 - ResearchAndMarkets.com
Tuesday, 01 January 2019 21:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: In Vitro Diagnostics
Read more...
 
<< Start < Prev 61 62 63 64 65 66 67 68 Next > End >>

Page 63 of 68

Newsletter